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AVP modulation of the vestibular nucleus
via V1b receptors potentially contributes to
the development of motion sickness in rat
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Abstract
Background: Arginine vasopressin (AVP) is considered to be an etiologic hormone in motion sickness (MS). The present
study was designed to investigate whether individual differences in AVP expression in the paraventricular nucleus (PVN)
and in modulation on the vestibular nucleus (VN) are involved in MS. Systemic application or microinjection of AVP into
rat VN and rotatory stimulus were used to induce conditioned taste aversion (CTA) to 0.15 % saccharin sodium solution
as a model of MS.
Results: Intra-VN use of SSR149415, an antagonist of V1b receptors (V1bRs), blunted CTA. AVP inhibited Ca2+ influxes
through L-type Ca2+ channels and NMDA receptor channels in cultured VN neurones, but antagonised by SSR149415.
More AVP and V1bRs were expressed respectively in the PVN and VN after rotatory stimulus, especially in rats susceptible
to MS. In the VN, AVP content was low, the AVP mRNA was less expressed, a few AVP-positive fibres were sparsely
distributed, and fewer AVP/synaptophysin-positive terminals were identified. Almost no fluoro-ruby-labelled AVP-positive
neurones in the PVN were found with retrograde tracing from the VN. SNP analysis of the reported 9 sites of the AVP
gene showed significant difference between the groups susceptible and insusceptible to MS at the site rs105235842 in
the allele frequencies and genotypes. However, there was not any difference between these two groups in the SNP of
the reported 38 sites of V1bR gene.
Conclusions: AVP, through its modulatory, possibly humoral action on the VN neurones via the mediation of V1bR, may
contribute to the development of motion sickness in rats; AVP gene polymorphisms may contribute to the individual
difference in the responsive expression of AVP in the PVN; and higher expressions of AVP in the PVN and V1bRs in the
VN may contribute to the development of motion sickness in rats after vestibular stimulation.
Keywords: Arginine vasopressin (AVP), V1b receptor, Rotatory stimulus, Motion sickness, Conditioned taste aversion,
Vestibular nucleus, Paraventricular nucleus
Background
Motion sickness is induced when humans receive an ab-
normal vestibular and/or visual stimulation while they
are in actual or virtual motion. It is commonly accepted
that central neuronal mechanisms are involved in the
development of motion sickness, as explained by the
sensory conflict theory [1–4], but the exact underlying
mechanisms are still unknown. In the last decade of the
20th century, it was reported that arginine vasopressin
(AVP) V1 receptor antagonists were effective in the pre-
vention of experimental motion sickness in squirrel mon-
keys [5, 6]. Moreover, plasma AVP levels markedly increase
during motion sickness [7–9], and intravenous or intra-
cerebroventricular perfusion of AVP could cause nausea or
vomiting in humans or in experimental animals [8–13].
Accordingly, AVP has been considered to be an etiologic
hormone in motion sickness [5, 8]. Kim et al. proposed
that the central, but not peripheral, actions of AVP might
contribute to nausea and slow wave disruption induced by
circular vection [8]. The study by Carpenter et al. suggests
that the emetogenic target of peptides (including AVP) that
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induced emesis in dogs may be in the area postrema [10].
However, the exact mechanism underlying the etiologic
effect of AVP in motion sickness in the central nervous
system remains unclear [8, 9, 11].
The results from a study by Abe et al. suggest that the
medial vestibular nucleus, the nucleus of the solitary
tract, the area postrema, and the paraventricular nucleus
(PVN) of the hypothalamus may be involved in the in-
duction of motion sickness by hypergravity in musk
shrew (Suncus murinus) [14]. It was found that there are
projections from the vestibular nucleus (VN) to the
PVN, and this pathway is likely polysynaptic [15, 16]. In
addition, the responses of PVN neurones induced by
vestibular stimuli also suggest a pathway from the VN to
the PVN [17]. Vestibular stimuli will increase the expres-
sion of AVP in the PVN [18] and the secretion of AVP
into the blood [7–9]. However, it is unclear whether
vestibular stimulus will strengthen the vasopressinergic
efferent activity of PVN. If the vestibular stimuli increase
the activity of PVN vasopressinergic efferent neurones,
AVP will likely induce vomiting through those efferent
pathways because there are efferent innervations from the
PVN to the emesis centres [19, 20]. On the other hand,
Kubo et al. found reciprocal connections between the
vestibular nuclei and the hypothalamus in their experi-
ments, suggesting a potential vasopressinergic pathway
from the PVN to the VN [21]. The PVN, as one of the
most important autonomic control centres in the brain,
may represent a unique central site at which multiple
input signals can be assessed and integrated such that a
complex multifactorial autonomic output can be generated
[22]. The PVN, through its vasopressinergic efferent influ-
ence on neurones in the VN we supposed, might thus play
an important role in the autonomic responses to motion
sickness-provoking stimuli, or alternatively, AVP, acting as
an etiologic hormone in motion sickness [5, 8] through its
humoral modulation on neurones in the VN, might in-
fluence the development of motion sickness.
Rats do not develop the symptoms of nausea and
vomiting because they lack the emetic reflex. However,
rats will produce conditioned taste aversion (CTA) after
a vestibular stimulus, which, as a substitute, has been
used as a behavioural index of motion sickness in rats
[23–27]. In the present study, we used CTA as an index
of motion sickness in rats to investigate whether AVP
modulation on neurones in the VN is involved in the in-
duction of motion sickness by rotatory stimulus and
whether the V1b receptors (V1bRs) of AVP in the VN
mediate the motion sickness-provoking effect of AVP.
Methods
Animals and chemicals
Sprague–Dawley rats (200–220 g body weight) of both
genders and pregnant (16 d) rats were obtained from the
Experimental Animal Center of Nantong University,
Nantong, China. Both genders of rats were equally allo-
cated to each group. All procedures used in this study
were in accordance with our institutional guidelines,
which comply with the international rules and policies and
were approved by the Animal Care and Use Committee of
Nantong University, Nantong, China.
Common inorganic salts were purchased in China and
culture mediums and Fluo 4-AM were obtained from
Invitrogen Corporation (Carlsbad, USA). The V1bR
antagonist SSR149415 was purchased from Axon
Medchem (Groningen, Netherlands). Cytosine β-D-
arabinofuranoside, sodium dodecylsulphate, AVP and
other chemicals, except those indicated elsewhere, were
purchased from Sigma-Aldrich Corporation (Saint
Louis, USA).
Motion sickness-inductive rotatory stimulus
The rotatory stimulator for use in small animals was
manufactured according to the report by Crampton and
Lucot [28]. Briefly, two clear lucite boxes are hung over
a frame that turns around a horizontal axis. An electric
motor drives the device, and a transducer (DZB60J
1.5 kW, Electric Fuling, Wenling, Zhejiang Province,
China) controls its time and rate of acceleration or de-
celeration, velocity, rotation duration, direction (clock-
wise and counter clockwise) and brake. Rats can move
freely in these boxes with unrestricted vision of the la-
boratory environment [27].
For the induction of motion sickness, rats were rotated
in the stimulator in an alternate acceleration and decel-
eration mode. The acceleration rate was 16 °/s2 for a
Table 1 List of AVP and V1b receptor gene SNP sites




rs8174376, rs8174377, rs104934522, rs104972087,
rs105131484, rs105281630, rs105361773, rs105397955,
rs105426072, rs105440759, rs105623482, rs105762638,
rs105845580, rs105862475, rs106031473, rs106081862,
rs106100029, rs106125862, rs106220176, rs106257682,
rs106366335, rs106372777, rs106473080, rs106531259,
rs106595881, rs106658396, rs106778661, rs106795491,
rs106849188, rs106924578, rs106967487, rs107136421,
rs107203534, rs107214944, rs107222006, rs107252548,
rs107371590, rs107406983
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duration of 7.5 s with a maximal velocity of 120 °/s, and
the deceleration rate was 48 °/s2 for a duration of 2.5 s.
The clockwise and counter clockwise rotations were
alternately repeated for 120 min. As suggested by the
literature [23–27], conditioned taste aversion served as
the index (“being sick”) of motion sickness. Before rota-
tory stimulus, 0.15 % saccharin sodium solution (SSS)
was supplied for the rats to drink for 45 min after they
had been deprived of water for 24 h and had become
familiar with this novel fluid one day before water
deprivation through free access to SSS in addition to tap
water for another 24 h. After a 24-h rest with free access
to tap water, the rats were subjected to rotatory stimu-
lus, and after another 24-h water deprivation, 0.15 % SSS
was then supplied for 45 min and the intake volume was
measured. The rats with intake volume decreases of less
than 15 % were considered to be insusceptible to motion
sickness, in contrast, the rats with intake volume de-
creases greater than 15 % were considered to be
susceptible.
For the experimental control, before and after the rota-
tory stimulus, control rats of both genders were supplied
with tap water instead of 0.15 % SSS for the same dura-
tions of 45 min after 24-h water deprivations. To avoid
the influence of water deprivation on AVP secretion, the
rats used for the above measures of taste aversion were
not included in the following determinations of AVP
expression.
Intracerebral microinjection
The rats were placed in a stereotaxic frame (Stoelting
Co., Wood Dale, USA) under an anaesthesia of 10 %
chloral hydrate (400 mg/kg, i.p.). Over a 15-min period,
0.1 μl of AVP and/or V1bR antagonist SSR149415 dis-
solved in normal saline was slowly injected into the ves-
tibular nucleus through a 1-μl microsyringe (Hamilton
Company, Reno, USA) with the coordinates of VN:
12.3 mm posterior to the bregma, 1.2 mm lateral to the
midline, and at a depth of 7.4 mm under the meninges
[29] and with a retention time of 5 min. Another side of
the VN was successively microinjected in the same way.
The vehicle rats were injected with an equal volume of
normal saline.
To observe whether local use of AVP in VN could in-
duce CTA, before intracerebral microinjection, a 0.15 %
saccharin sodium solution was supplied for the rats to
drink for 45 min after they had been deprived of water
for 24 h and had become familiar with this solution one
day before water deprivation through free access to SSS
in addition to tap water for another 24 h. After a 24-h
rest with free access to tap water, a bilateral microinjec-
tion of AVP (10 ng or 30 ng for each side), SSR149415
(5.7 ng or 17.2 ng for each side) or their combination
into the VN was performed, the rats were deprived of
water for another 24-h period and were then given an-
other 45-min of free access to SSS. The intake volume of
SSS was measured, and changes after the AVP micro-
injection were calculated.
To investigate whether the AVP V1bR antagonist also
influences the induction of CTA after rotatory stimula-
tion, SSR149415 (5.7 ng for each side) was microin-
jected bilaterally into the VN. AVP microinjection was
substituted with a 2-h rotatory stimulus; the other
Table 2 Primer pairs of AVP and V1b receptor genes
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procedures were the same as those in the AVP micro-
injection experiment.
To observe whether local use of the AVP V1bR an-
tagonist in VN blocks the motion sickness-inductive
effect by systemic use of AVP, rotatory stimulus was
substituted with an intraperitoneal injection of AVP
(100 μg/kg) to induce CTA; the other procedures were
the same as those of above SSR149415 (5.7 ng for each
side) microinjection experiment and rotatory stimulus-
induced CTA.
To retrogradely trace AVP fibres that potentially ter-
minate in the VN, a retrograde tracer Fluoro-ruby (10 %,
0.15 μl) was microinjected into the right side of the VN
for 3 min, and the micropipette was left in place for
5 min before withdrawal to minimise the leaking of the
tracer. After 8 days, the animals received an anaesthesia
with 10 % chloral hydrate followed with the slicing of
the rat brain tissue, immunohistochemistry, and micro-
scopic observations.
Nissl staining and immunohistochemistry in brain tissue
The rats were anaesthetised with 10 % chloral hydrate
(400 mg/kg, i.p.) and perfused with 200 ml of saline
and then with 4 % paraformaldehyde in 0.1 M phos-
phate buffered saline (PBS, pH 7.4). The rat brains
were then removed and post-fixed for 24 h in the
same fixative. The post-fixed brains were dry-
protected in PBS containing 30 % sucrose. For Nissl
staining, the brains were sectioned into slices of
30 μm in thickness with a cryostat slicer (CM1900,
Leica, Bensheim, Germany). For immunofluorescent
staining, the brains were sectioned coronally with a
thickness of 5 μm.
For Nissl staining, the brain sections were mounted
with neutral balata and blotted onto slides before be-
ing processed through different baths in the following
order (and times): chloroform (30 min), acetone
(15 min), 100 % ethanol (30 s), 95 % ethanol (30 s),
70 % ethanol (30 s), distilled water (30 s, twice), cre-
syl violet (20 min), distilled water (30 s, three times),
70 % ethanol (1 min), 95 % ethanol (1 min), 100 %
ethanol (1 min), chloroform (5 min), differentiator
(95 % ethanol, added glacial acetic acid till pH was
4.1) (6 min), 95 % ethanol (2 min), 100 % ethanol
(3 min, twice), xylene (2 min), and xylene (3 min,
twice); they were then covered with a coverslip.
For immunofluorescent staining, the brain sections
were blocked and permeabilised with 0.3 % Triton X-
100 and 8 % normal donkey serum (Jackson, West
Grove, USA) in PBS. The sections were then incu-
bated with 0.3 % Triton X-100 and 4 % normal don-
key serum in PBS containing primary antibodies in
the following dilutions: rabbit anti-AVP (EMD Milli-
pore Corporation, Billerica, USA) 1:2000 and mouse
anti-synaptophysin (EMD Millipore Corporation, Bil-
lerica, USA) 1:2000 overnight at 4 °C. The secondary
antibodies used were donkey anti-rabbit Alexa-488 and
donkey anti-mouse Alexa-594 or donkey anti-rabbit
Alexa-647 (1:1000, Jackson, West Grove, USA) for 2 h at
room temperature. The sections were imaged using a con-
focal microscope (TCS SP8, Leica Microsystems, Wetzlar,
Germany).
Fig. 1 Induction of CTA by a rotatory stimulus or intra-vestibular nuclei microinjection of AVP and the effects of the V1bR antagonist (n = 10).
a, indication of the microinjection area in the VN (Nissl staining). b, induction of CTA by AVP microinjection into the VN and the blocking
effect of V1bR antagonist SSR149415. c, induction of CTA after rotatory stimulus and the blocking effect of SSR149415 microinjection into the
VN. d, induction of CTA after AVP intraperitoneal injection (i.p.) and the blocking effect of SSR149415 microinjection into the VN. *P < 0.05, **P < 0.01, vs.
vehicle; #P < 0.05, ##P < 0.01 vs. AVP 10 ng or 30 ng groups, respectively; ΔP < 0.05, vs. AVP (i.p.) used alone
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Enzyme-linked immunosorbent assay (ELISA)
Two hours after rotatory stimulus, the rat brains were
harvested under anaesthesia (10 % chloral hydrate,
400 mg/kg, i.p.), and were sliced in the ice-cold artificial
cerebral-spinal fluid to a thickness of 350 μm with a
vibratome (Campden Instruments, UK). According to
the location of the VN and PVN in the brain atlas [29],
the tissues of these two areas were cautiously isolated
for the following measurements including ELISA, real-
time quantitative PCR (qRT-PCR) and western-blot
analysis.
The content of AVP in the VN and PVN was mea-
sured with ELISA. The tissues of the VN and PVN were
isolated and stored at −80 °C until use. The brain tis-
sues were homogenised and centrifuged at 4 °C and
14,000 rpm for 30 min. The supernatants were trans-
ferred to new eppendorf tubes and assayed in duplicate
using AVP assay kits (R&D Systems, Minneapolis,
USA) according to the manufacturer’s guidelines.
Real-time quantitative PCR
The tissues isolated from the rat brains were homogenised
in Trizol reagent (Invitrogen Corporation, Carlsbad,
USA), and the total RNA was purified. Potential con-
tamination of DNA was removed using DNase, and
1 μg of RNA was used for first strand complementary
DNA (cDNA) synthesis by retrotranscription using
oligodT primers and the PrimeScript RT Reagent Kit
(Tiangen Biotech Co., Ltd, Beijing, China) according to
the manufacturer's instructions. qRT-PCR reactions
were carried out in a Rotor-Gene PCR machine (RG-
3000A, Corbett Research Proprietary Limited, New
South Wales, Australia), and the detailed procedures
were as follows: an initial denaturation step at 95 °C for
5 s, followed by 40 cycles of a 95 °C denaturation for
5 s, 60 °C annealing for 20 s, and 72 °C extension for
30 s. The amounts of cDNA per sample were deter-
mined using a SYBR Premix Ex Taq™ kit (Roche, Basel,
Switzerland). The progression of the PCR reactions was
assessed by changes in the SYBR green dye fluorescence
attached to double stranded DNA. All values were nor-
malised to the housekeeping gene β-actin. The primers
used for qRT-PCR were: AVP forward: 5′-CTCGGGAGC
AGAGCAACG-3′, reverse: 5′-GGGGCGATGGCTCA
GTAG-3′; V1bR forward: 5′-GGGCAGATTTCTACTT




The brain tissues were lysed in 1 ml of tissue lysis solution
containing phenylmethanesulfonyl fluoride (Beyotime,
Fig. 2 The influence of AVP on KCl-elicited Ca2+ influx (n = 20). a, examples of Ca2+ imaging. b, mean values of Ca2+ influx changes after different
treatments. c, mean peak values of Ca2+ influx after different treatments. **P < 0.01, vs. KCl group. ##P < 0.01, vs. KCl + AVP group
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Nantong, China), and then centrifuged at 13,400 × g for
15 min at 4 °C. The protein content of the supernatant
was determined spectrophotometrically using the
bicinchoninic acid method. Equal amounts of protein
(40 μg per lane) from each sample were loaded on a
10 % sodium dodecyl sulphate-polyacrylamide gel, elec-
trophoresed, and transferred onto the polyvinyledene
difluoride membranes (Millipore, Massachusetts, America).
These membranes were blocked in 5 % non-fat milk in
Tris-buffered saline containing 0.1 % Tween-20 for 2 h at
room temperature and were incubated overnight at 4 °C
with primary antibodies (diluted in Tris-buffered saline
containing 0.1 % Tween-20 with 5 % non-fat milk), V1bR
(1:500, Lifespan, BioSciences, Inc., Seattle, USA) and
GAPDH (1:6000, Sigma-Aldrich Corporation, Saint Louis,
USA). After incubating the blots with rabbit anti-goat IgG
(H + L)-HRP (1:10000, Bioworld, Nanjing, China) for 2 h at
room temperature, the immunoreactive bands were
visualised by the enhanced chemiluminescence (Prierce
Biotechnology, Rockford, USA) and exposed to X-ray
film (Eastman Kodak Company, Rochester, USA). The
images were captured using an EC3 Imaging System,
and the protein levels were quantified using Image-Pro
Plus. The same samples were analysed repeatedly for a
minimum of two times.
Cell culture
Primary vestibular nuclei cultures were established from
the embryonic (16 d) rats. Foetuses were removed from
the uterus and placed in sterile ice-cold Hank's balanced
salt solution (Gibco, Carlsbad, USA). The foetal rat
brains were removed with the aid of a dissecting micro-
scope by dissection of the skull using fine-tipped watch-
maker’s forceps. The vestibular nuclei were carefully
dissected from the brain stem, and the blood vessels,
meninges and other brain tissues were removed. The
tissue matrix was loosened by treatment with 0.25 %
trypsin (Life Technologies, Carlsbad, USA) for 6 min at
37 °C in a shaking water bath.
After mechanical trituration and centrifugation, the
resulting cell pellet was resuspended in Dulbecco's Mini-
mum Essential Medium containing 10 % foetal bovine
serum, 1 % GlutaMAX, and 1 % penicillin-streptomycin
(all from Life Technologies). The cells were seeded at a
density of 1 × 105 cells per well in 24-well poly-D-lysine-
coated plates. Four hours later, the medium was changed
with neurobasal medium (Life Technologies) supple-
mented with 2 % B27 (Life Technologies), 1 % GlutaMAX
and 1 % penicillin-streptomycin. The cultures were main-
tained by a 50 % media exchange every 3 days for at least
12 days. The day of plating was counted as day-in-vitro 0.
Fig. 3 The influence of AVP on NMDA-elicited Ca2+ influx (n = 20). a, examples of Ca2+ imaging. b, mean values of Ca2+ influx changes after different
treatments. c, mean peak values of Ca2+ influx after different treatments. **P < 0.01, vs. NMDA group. ##P < 0.01, vs. NMDA + AVP group
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On day-in-vitro 3, cytosine-β-D-arabinofuranoside (5 μM,
Sigma-Aldrich Corporation, Saint Louis, USA) was added
to suppress the proliferation of glial cells for 3 days
followed by a return to regular neurobasal medium. The
cell plates were maintained at 37 °C in a humidified 5 %
CO2 incubator.
Intracellular Ca2+ imaging
For the imaging of the intracellular free Ca2+, Fluo 4-AM
(the acetoxymethyl-ester form of Fluo 4) was used as a
fluorescent Ca2+ indicator. The cultured vestibular nuclei
neurones on day-in-vitro 12 were loaded with 5 μM Fluo
4-AM in extracellular solution for 45 min at 37 °C. After
being washed three times with normal extracellular solu-
tion, the neurones were incubated at 37 °C for another
30 min to complete the deesterification of Fluo 4-AM.
The intensity of fluorescence with the excitation wave-
length at 485 nm and an emission wavelength at 525 nm
was recorded every 10 s using a laser scanning confocal
microscope (TCS SP8, Leica Microsystems). All image
data were collected and analysed with the Leica Control
software of the microscope. The increase of intracellular
free Ca2+ was determined according to the following equa-
tion: Ca2+ influx (%) = (F525 − Fbase, 525) / Fbase, 525 × 100,
where F525 is the fluorescence intensity measured after
each treatment and Fbase, 525 is the basal fluorescence in-
tensity. A high extracellular K+ solution containing (in
mM): 98 NaCl, 50 KCl, 10 HEPES, 3 CaCl2°2H2O, 2
MgCl2°6H2O, and 8 glucose was used for the induction of
Ca2+ influx through the L-type Ca2+ channels. A NMDA
solution containing (in mM): 98 NaCl, 1 NMDA, 10
HEPES, 3 CaCl2°2H2O, 2 MgCl2°6H2O, and 8 glucose was
used for the induction of Ca2+ influx through the NMDA
receptor channels.
The analysis of single nucleotide polymorphism (SNP) of
the AVP and V1bR genes
Whole brain tissues of rats were isolated under anaes-
thesia with 10 % chloral hydrate (400 mg/kg, i.p.).
Genomic DNA was extracted from the rat brains using
an AxyPrep Genomic DNA Mini Preparation Kit
(Axygen Scientific, Inc., Union City, USA) following
the manufacturer’s protocol and checked for concentra-
tion and purity using a NanoDrop 2000 Biophotometer
(Thermo Scientific, Milford, USA). Primers for the AVP
and V1bR genes (NC_005102.2 and NC_005112.2) for
SNP analysis were designed using Primer Premier 5.0 soft-
ware (PREMIER Biosoft, Palo Alto, USA), with technology
support by Shanghai R & S Co., Ltd. According to the re-
ported 9 sites of AVP gene SNP and the 38 sites of V1bR
gene SNP listed in NCBI through March 2011 (Table 1,
http://www.ncbi.nlm.nih.gov/pubmed/), we designed pri-
mer pairs of 5 fragments in the AVP gene and 13 frag-
ments in the V1bR gene, as shown in Table 2.
To obtain higher accuracy, amplification of the AVP
sequences using Taq high-fidelity DNA polymerase
was performed. Semi-quantitative RT-PCR was carried
out in a 50 μL reaction volume containing 10 × buffer
5 μL, MgSO4 (50 mM) 2 μL, dNTP (10 mM) 1 μL,
and with each of the forward and reverse primers
(10 μM) 1 μL, DNA 1 μL, Taq HIFI (5 U/μL, Invitro-
gen Corporation) 0.2 μL, and ddH2O added to the
final volume. The PCR cycling protocol was an initial
denaturation at 95 °C for 5 min, 35 cycles of 95 °C
denaturation for 30 s, 57–65 °C annealing for 30 s,
and 68 °C extension for 30 s. The PCR products of
3 μL were separated by electrophoresis in a 1.5 %
agarose gel to verify their integrity, the others were
purified using a PCR purification kit (Axygen Scientific,
Inc.) following the manufacturer’s protocol. The purified
products were sequenced by ABI 3730xl DNA analyser
(Applied Biosystems, Carlsbad, USA) to analyse the SNP
information.
Fig. 4 The expression of V1bR in the VN with and without rotatory
stimulus. a, expression of V1bR mRNA (n = 8). b, examples of the V1bR
protein expression. Subgroups correspond to the columns of (a) and
(c). c, mean values of the V1bR protein expression (n = 6). **P < 0.01, vs.
control; #P < 0.05, vs. susceptible group after rotatory stimulus
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Statistical analysis
All data are presented as the mean ± s.e.m. Student’s t-
tests of paired or unpaired observations were used, re-
spectively, for the comparisons of two groups, paired
or unpaired. One-way ANOVA was used for the com-
parison of three or more groups, and the Least Signifi-
cant Difference test was used for post hoc comparisons
between the two groups. The chi-square test was used
for the comparison of rates in the SNP analysis of AVP
and V1bR genes. Differences were considered statisti-
cally significant at a level of P < 0.05.
Results
Induction of CTA and mediation through V1bR in VN
Nissl staining of the brain slices was performed immedi-
ately after the behavioural tests of CTA to identify
whether the microinjection sites were bilaterally right in
the VNs (Fig. 1a). Data from rats (about 2–3 animals for
each group) with injections bilaterally asymmetrical or
not right in the VNs were not included in the following
results. In addition, the negative control experiments re-
vealed that there were not any differences in the intake
volume of tap water before and after different treatments
including rotatory stimulus, AVP injection or use of
AVP V1bR antagonist. Similar to rotatory stimulus,
microinjection of AVP into the vestibular nuclei induced
CTA in rats, i.e., corresponding to an intra-vestibular
nuclei microinjection of 10 ng or 30 ng of AVP, the in-
take volume of SSS decreased compared with that before
microinjection (Fig. 1b). However, when AVP V1bR an-
tagonist SSR149415 was injected at the same time, the
decrease in the intake volume of SSS elicited by AVP
was significantly inhibited. In addition, to identify the
involvement of V1bR in the induction of rotatory stimu-
lation- and AVP intraperitoneal injection-induced CTA,
we also observed the effect of SSR149415 injection into
Fig. 5 The expression of AVP in the PVN and the distribution of AVP-positive fibres in the VN. a, AVP expression in the PVN of susceptible and
insusceptible groups with and without rotatory stimulus (n = 6); b, net increase of AVP expression in the PVN after rotatory stimulus (n = 6); c,
labelling of AVP and synaptophysin; d, another section labelling AVP and synaptophysin and further magnification to reveal AVP fibre terminals that express
synaptophysin. Four rats, two for each gender, were used in (c) and (d). *P< 0.05, **P< 0.01, vs. control. Scale bar, 20 μm for (c), 5 μm for (d)
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the vestibular nuclei. As a result, microinjection of
SSR149415 into the VN also inhibited rotatory stimu-
lus- and AVP intraperitoneal injection-induced CTA in
rats (Fig. 1c and d). These results suggest that rotatory
stimulation-induced motion sickness in rats is likely
related to humoral modulation by AVP in the vestibular
nuclei through V1bR.
The inhibitory influence of AVP on L-type voltage-
dependent Ca2+ channels in cultured VN neurones
Ca2+ influx was enhanced prominently when KCl
(50 mM) was infused into the cultured VN neurones
(Fig. 2). This enhancement was inhibited by pre-
incubation with 100 nM AVP in the extracellular solu-
tion for 60 min (P < 0.01, Fig. 2). The addition of AVP
(100 nM) or V1bR antagonist SSR149415 (100 nM)
alone did not elicit any notable Ca2+ influx. Pre-
incubation of SSR149415 with AVP in the extracellular
solution for 60 min removed the inhibitory effect of
AVP on the KCl-elicited Ca2+ influx (P < 0.01, Fig. 2).
The inhibitory influence of AVP on NMDA receptors in
cultured VN neurones
Perfusion of NMDA (1 mM) to the cultured VN neu-
rones remarkably elicited an influx of Ca2+ (Fig. 3). The
addition of AVP (100 nM) or V1bR antagonist
SSR149415 (100 nM) alone did not elicit an influx of
Ca2+ (Fig. 3). After the pre-incubation of AVP for
60 min, the NMDA-elicited Ca2+ influx was significantly
inhibited (P < 0.01, Fig. 3), but pre-incubation of
SSR149415 with AVP in the extracellular solution for
60 min blunted the inhibitory effect of AVP on the
NMDA-elicited Ca2+ influx (P < 0.01, Fig. 3).
The expression of V1bR in the VN
As shown in Fig. 4a, no significant changes were found
in the expression of V1bR mRNA in the VN between
the groups with and without rotatory stimulus. However,
the expression of V1bR protein was elevated after rota-
tory stimulus, especially in the group susceptible to mo-
tion sickness (Fig. 4b).
The expression of AVP in the PVN and the distribution of
AVP positive fibres and vasopressinergic nerve endings in
the VN
The expression level of AVP mRNA (relative to β-actin)
in the PVN was 0.7219 ± 0.1062 (n = 6). However, the ex-
pression level of AVP mRNA in VN was 0.0090 ± 0.0008
(n = 6), which was much lower than that in the PVN. It
is suggested that the VN itself possibly does not synthe-
sise AVP. Then, we measured the expression level of
AVP in the PVN and VN with ELISA. The AVP level in
the VN was much lower than that in the PVN and was
not significantly changed after rotatory stimulation (data
not shown). As shown in Fig. 5a, the expression of AVP in
the PVN was elevated after rotatory stimulus, especially in
rats of the group susceptible to motion sickness (Fig. 5b).
A sparse distribution of AVP-positive fibres in the VN
was found using immunofluorescent staining method,
but no AVP-positive cells were identified in the VN
(Fig. 5c and d). In addition, we did not find a notable dif-
ference in the distribution of AVP-positive fibres in the
VN between the susceptible and insusceptible groups. To
find vasopressinergic nerve endings in the VN, a double
labelling method was used to reveal AVP and synaptophy-
sin, a marker of vesicles that is present in both the synap-
tic vesicles and the large dense-cored vesicles [30–33]. As
a result, very few double labelling puncta were found
(Fig. 5c and d), suggesting that there are few vasopressi-
nergic nerve endings that terminate in the VN.
Retrograde tracking of AVP fibres to the VN
To further identify whether there are abundant vasopressi-
nergic nerve fibre innervations in the VN originated from
Fig. 6 Retrograde tracking of AVP fibres from the PVN to the VN.
Four rats, 2 for each gender, were used. Serial sections covering the
PVN were taken from each animal for observation. a, AVP-positive
cells in the PVN; b, fluoro-ruby-labelled cells through retrograde
tracking from the VN; c, merge of (a) and (b) and further
magnification. Scale bar, 75 μm
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the PVN, we performed additional observation through
retrograde tracking of AVP fibres to the VN. As shown in
Fig. 6, eight days after injection of fluoro-ruby into the
VN, only some small cells in the PVN without notable
AVP labelling (green) were bilaterally labelled with fluoro-
ruby (red), suggesting that there are not vasopressinergic
nerve fibres in the PVN that directly innervate the VN
neurones.
The difference in single nucleotide polymorphisms of the
AVP and V1bR genes
Single nucleotide polymorphism analysis of the reported
9 sites in the AVP gene showed that at the site rs105235842
(functional consequence: upstream variant 2 KB, http://
www.ncbi.nlm.nih.gov/snp/?term=rs105235842), a differ-
ence between the susceptible and insusceptible groups was
found in the allele frequencies and genotypes (P < 0.01,
Table 3), where single nucleotide T was the dominant allele.
In addition, at the site rs197835086 (functional conse-
quence: intron variant, http://www.ncbi.nlm.nih.gov/
snp/?term=rs197835086), a difference between the sus-
ceptible and insusceptible groups was found in the ge-
notypes, but was statistically insignificant (P = 0.0617,
Table 4), where single nucleotide A was the dominant
allele.
SNP analysis revealed that there was not any differ-
ence between the susceptible and insusceptible groups
of rats in the SNP of the reported 38 sites in the V1bR
gene we investigated in the present study.
Discussion
In the present study, we first proved that the bilateral
microinjection of AVP into vestibular nuclei, similar to a
rotatory stimulus, induced conditioned taste aversion in
rats and that the application of SSR149415, an antagon-
ist of AVP V1bR, blunted this CTA-inducing effect of
AVP and rotatory stimulus-induced CTA, suggesting
that AVP, through its action on the VN, could contribute
to the development of motion sickness in rats via the
mediation of V1bR. In addition, we found that AVP
inhibited Ca2+ influxes through L-type Ca2+ channels
and NMDA receptor channels in cultured VN neurones,
and this effect was reduced in the presence of the V1bR
antagonist SSR149415, indicating that AVP potentially
exerts an inhibitory influence on the activity of VN neu-
rones via V1bR. This inhibitory influence is consistent
with the in vivo results reported by Podda et al. [34].
Ballesteros and Gallo found that a bilateral blockade of
the lateral vestibular nucleus by tetrodotoxin microinjec-
tions could also induce CTA, which is consistent with
our results [35]. Furthermore, the expression of V1bR in
the VN was confirmed with qRT-PCR and western-blot
analysis in the present study and had a greater expres-
sion after rotatory stimulus, especially in the rats suscep-
tible to motion sickness. This finding is consistent with
our previous results concerning the V1bR-positive cells
in the VN of rat after rotatory stimulus observed using
the immunofluorescence imaging method [36].
Moreover, the present study found low expressions of
AVP mRNA and no AVP-positive cells in the VN, sug-
gesting that the VN itself possibly does not have vaso-
pressinergic cells to synthesise AVP. Thereby, the lower
content of AVP found in the VN is consistent with this
suggestion. However, some AVP-positive fibres and few
AVP/synaptophysin-positive fibres in the VN were found
in the present study. In addition, few fluoro-ruby-
labelled AVP-positive neurones in the PVN were found
using the retrograde tracing method. These results sug-
gest that there are few vasopressinergic nerve endings
that terminate in the VN of rats and that there are not
direct innervations in the VN of AVP-positive fibres ori-
ginating from the PVN. AVP existing in the fibres pass-
ing through the VN is likely the source of the low levels
of AVP in the VN.
Therefore, to modulate the vestibular neurones, we
suggest that AVP might come from the blood stream or
Table 3 Allele frequencies and genotypes of rat AVP gene site (rs105235842)
Group Number Genotype (%) Allele frenquency (%)
T/T C/C T/C T C
Susceptible to motion sickness 12 41.7 (5) 0 (0) 58.3 (7) 70.8 29.2
Iinsusceptible to motion sickness 12 100 (12) 0 (0) 0 (0) 100 0
χ2 = 9.471, P = 0.0046 χ2 = 8.195, P = 0.0094
Table 4 Allele frequencies and genotypes of rat AVP gene site (rs197835086)
Group Number Genotype (%) Allele frenquency (%)
A/A G/G A/G A G
Susceptible to motion sickness 12 50.0 (6) 0 (0) 50.0 (6) 75.0 25.0
Insusceptible to motion sickness 12 83.3 (10) 8.3 (1) 8.3 (1) 87.5 12.5
χ2 = 3.573, P = 0.0617 χ2 = 1.231, P = 0.4614
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from cerebrospinal fluid (CSF). The location of the ves-
tibular nucleus that dorsally borders the floor of the
fourth cerebral ventricle affords the convenience for the
potential modulation of AVP from CSF [37]. Crampton
and Daunton found evidence for a motion sickness agent
in the CSF of cats, but whether AVP was the humoral
motion sickness substance was a matter of conjecture at
that time [38]. Moreover, it is reported that plasma AVP
levels increase markedly during motion sickness [7–9]
and that intravenous or intracerebroventricular perfu-
sion of AVP indeed causes nausea or vomiting in
humans and experimental animals [8–13]. AVP has been
considered as an etiologic hormone in the development
of motion sickness [5, 8]. We also found an increase in
AVP levels in the blood after motion sickness-inductive
rotatory stimulation in both dogs and rats [39, 40]. In
the present study, our further experiment revealed that
bilateral microinjection of SSR149415 into the VN
blunted the CTA induced by intraperitoneal injection of
AVP. Thus, combined with the present results and those
from other studies [5–13], we postulate that AVP might
be the candidate of motion sickness-provoking agent in
the CSF or in the blood and that the VN might be one
of the most important candidates targeted by AVP.
In the present study, we found that the AVP levels in
the PVN were elevated after rotatory stimulus, especially
in rats susceptible to motion sickness, which was consist-
ent with other studies showing that vestibular stimulus in-
creased the AVP-expressing cells in the PVN [18], which
is likely the source of AVP secreted into blood during the
development of motion sickness [7–9] or after motion
sickness-inductive rotatory stimulation [39, 40]. Moreover,
the expression of V1bR protein in the VN was elevated
after rotatory stimulus, especially in the group susceptible
to motion sickness. These results suggest that the relative
high sensitivity of rats susceptible to motion sickness is
likely associated with a greater expression of AVP in the
PVN and increased expression of AVP V1bR in the VN.
To investigate the potential mechanisms of these differ-
ences in the expression of AVP and V1bR in rats of differ-
ent susceptibility to motion sickness, the SNPs of the
reported 9 sites in the AVP gene and 38 sites in the
V1bR gene were analysed. We found that at the SNP
site rs105235842, a difference between the susceptible
and insusceptible groups was found in the allele fre-
quencies and genotypes, and at the site rs197835086,
a difference between the susceptible and insusceptible
groups was found in the genotypes. The SNP site
rs105235842 is an upstream variant of the AVP gene
(http://www.ncbi.nlm.nih.gov/snp/?term=rs105235842),
and the SNP site rs197835086 is an intron variant
(http://www.ncbi.nlm.nih.gov/snp/?term=rs197835086).
These two variances may influence the transcription of
the AVP gene and result in the difference in the
expression levels of AVP, especially when rats are sub-
jected to rotatory stimulation.
However, we did not find any difference between the
susceptible and insusceptible groups of rats in the SNPs
of 38 sites of the V1bR gene that we investigated in the
present study. It is suggested that in the 38 sites of the
V1bR gene, SNPs are not involved in the difference of
motion sickness susceptibility in rats.
Conclusions
The present results suggest that AVP, through its modu-
latory, possibly humoral action on the VN neurones via
the mediation of V1bR, may contribute to the develop-
ment of motion sickness in rats; AVP gene polymor-
phisms may contribute to the individual difference in
the responsive expression of AVP in the PVN; and
higher expressions of AVP in the PVN and V1bRs in the
VN may contribute to the development of motion sick-
ness in rats after vestibular stimulation.
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